Abstract
The management of rapidly progressive glomerulonephritis has been transformed over the past thirty years. It has become one of the few forms of glomerulonephritis that can be effectively treated, and today overall renal survival is as high as 70%. Effective management of patients with RPGN requires prompt and accurate diagnosis so that patients are appropriately treated, and long term follow up to minimise the risk of relapse in patients with some types of those disease.
Original language | English |
---|---|
Pages (from-to) | S111-S119 |
Number of pages | 9 |
Journal | Journal of Nephrology |
Volume | 12 |
Publication status | Published - 1999 |
Keywords
- rapidly progressive glomerulonephritis
- vasculitis
- goodpastures disease
- ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES
- IDIOPATHIC CRESCENTIC GLOMERULONEPHRITIS
- WEGENERS GRANULOMATOSIS
- SYSTEMIC VASCULITIS
- MONOCLONAL-ANTIBODY
- GOODPASTURE ANTIGEN
- ENDOTHELIAL-CELLS
- DISEASE-ACTIVITY
- NECROTIZING GLOMERULONEPHRITIS
- EXPRESS PROTEINASE-3